• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依那西普治疗家族性地中海热患者的关节炎

Etanercept in the treatment of arthritis in a patient with familial Mediterranean fever.

作者信息

Sakallioglu O, Duzova A, Ozen S

机构信息

Pediatric Nephrology and Rheumatology Unit, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.

出版信息

Clin Exp Rheumatol. 2006 Jul-Aug;24(4):435-7.

PMID:16956436
Abstract

Familial Mediterranean fever (FMF) patients may present with different joint complaints, one being the 'protracted attack' that lasts for weeks. We present a 15 year-old boy with polyarthritis (right wrist, knee, shoulder, and both ankles) while on colchicine treatment for FMF. His polyarthritis was resistant to treatment with prednisolone and methotrexate, and etanercept was instituted (0.8 mg/kg/week). He responded dramatically to etanercept and remained in full remission, although the drug was stopped at 4 months due to social and financial causes. We suggest that anti-TNF drugs may be an alternative for resistant attacks. However the timing and dosage, as well as efficacy, need to be further studied.

摘要

家族性地中海热(FMF)患者可能出现不同的关节症状,其中一种是持续数周的“迁延性发作”。我们报告一名15岁男孩,患有FMF,正在接受秋水仙碱治疗,出现了多关节炎(右腕、膝、肩和双踝)。他的多关节炎对泼尼松龙和甲氨蝶呤治疗无效,遂开始使用依那西普(0.8 mg/kg/周)。他对依那西普反应显著,一直处于完全缓解状态,不过由于社会和经济原因,该药物在4个月时停用。我们认为抗TNF药物可能是治疗难治性发作的一种选择。然而,其使用时机、剂量以及疗效仍需进一步研究。

相似文献

1
Etanercept in the treatment of arthritis in a patient with familial Mediterranean fever.依那西普治疗家族性地中海热患者的关节炎
Clin Exp Rheumatol. 2006 Jul-Aug;24(4):435-7.
2
Sacroileitis and pericarditis: atypical presentation of tumor necrosis factor receptor-associated periodic syndrome and response to etanercept therapy.骶髂关节炎和心包炎:肿瘤坏死因子受体相关周期性综合征的非典型表现及对依那西普治疗的反应
Clin Exp Rheumatol. 2010 Mar-Apr;28(2):290-1. Epub 2010 May 14.
3
Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.肿瘤坏死因子拮抗剂治疗对秋水仙碱治疗抵抗的伴有慢性关节炎和/或骶髂关节炎的家族性地中海热患者的疗效。
J Clin Rheumatol. 2011 Oct;17(7):358-62. doi: 10.1097/RHU.0b013e31823682f5.
4
Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine.抗白细胞介素 1 治疗对秋水仙碱耐药的家族性地中海热患者。
J Rheumatol. 2011 Mar;38(3):516-8. doi: 10.3899/jrheum.100718. Epub 2010 Dec 15.
5
Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to colchicine: anti-TNF drugs and FMF.肿瘤坏死因子-α(anti-TNF)拮抗剂成功治疗对秋水仙碱耐药的家族性地中海热(FMF)患者的蛋白尿:抗 TNF 药物与 FMF。
Rheumatol Int. 2012 Apr;32(4):1095-7. doi: 10.1007/s00296-011-1855-5. Epub 2011 Mar 23.
6
Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents.秋水仙碱耐药的家族性地中海热患者的治疗选择:沙利度胺和依那西普作为辅助药物
Clin Exp Rheumatol. 2006 Sep-Oct;24(5 Suppl 42):S99-103.
7
Familial Mediterranean fever successfully treated with etanercept.依那西普成功治疗家族性地中海热。
J Clin Rheumatol. 2007 Feb;13(1):38-40. doi: 10.1097/01.rhu.0000255772.25658.7c.
8
A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study.依那西普与甲氨蝶呤联合治疗难治性幼年特发性关节炎的一项初步研究。
Ann Rheum Dis. 2001 Apr;60(4):410-2. doi: 10.1136/ard.60.4.410.
9
The medical odyssey of a boy with arthritis of familial Mediterranean fever.一个患有家族性地中海热关节炎男孩的医学历程。
Int J Rheum Dis. 2012 Apr;15(2):e37-9. doi: 10.1111/j.1756-185X.2011.01686.x. Epub 2011 Dec 18.
10
Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.儿童和青少年中对秋水仙碱耐药的家族性地中海热的治疗。
Rheumatol Int. 2015 Oct;35(10):1733-7. doi: 10.1007/s00296-015-3293-2. Epub 2015 May 23.

引用本文的文献

1
Treat-to-target strategies for the management of familial Mediterranean Fever in children.针对儿童家族性地中海热的靶向治疗策略。
Pediatr Rheumatol Online J. 2023 Sep 26;21(1):108. doi: 10.1186/s12969-023-00875-y.
2
Interventions for reducing inflammation in familial Mediterranean fever.家族性地中海热的抗炎干预措施。
Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD010893. doi: 10.1002/14651858.CD010893.pub4.
3
Efficacy of anti-interleukin-1 treatment in colchicine-resistant arthritis in patients with familial Mediterranean fever.
抗白细胞介素-1治疗对家族性地中海热患者秋水仙碱抵抗性关节炎的疗效
Eur J Rheumatol. 2021 Jan;8(1):16-19. doi: 10.5152/eurjrheum.2020.20126. Epub 2020 Sep 18.
4
Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review.家族性地中海热,从发病机制到治疗:当代综述。
Turk J Med Sci. 2020 Nov 3;50(SI-2):1591-1610. doi: 10.3906/sag-2008-11.
5
Update on the management of colchicine resistant Familial Mediterranean Fever (FMF).关于难治性家族性地中海热(FMF)的管理进展。
Orphanet J Rare Dis. 2019 Oct 15;14(1):224. doi: 10.1186/s13023-019-1201-7.
6
Colchicine plus Dapsone in Colchicine-Resistant FMF Patients.秋水仙碱联合氨苯砜治疗对秋水仙碱耐药的家族性地中海热患者
Case Rep Rheumatol. 2019 Jan 9;2019:2716127. doi: 10.1155/2019/2716127. eCollection 2019.
7
The Influence of Concomitant Disorders on Disease Severity of Familial Mediterranean Fever in Children.合并症对儿童家族性地中海热疾病严重程度的影响。
Arch Rheumatol. 2017 Oct 30;33(3):282-287. doi: 10.5606/ArchRheumatol.2018.6488. eCollection 2018 Sep.
8
TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy.TNF/TNFR 轴促进 pyrin 炎性小体的激活,并显著调节 pyrin 炎性小体病。
J Clin Invest. 2019 Jan 2;129(1):150-162. doi: 10.1172/JCI121372. Epub 2018 Nov 19.
9
Interventions for reducing inflammation in familial Mediterranean fever.降低家族性地中海热炎症的干预措施。
Cochrane Database Syst Rev. 2018 Oct 19;10(10):CD010893. doi: 10.1002/14651858.CD010893.pub3.
10
The development and assessment of biological treatments for children.儿童生物治疗的开发与评估。
Br J Clin Pharmacol. 2015 Mar;79(3):379-94. doi: 10.1111/bcp.12406.